caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1932206836

Soo ChongM.D.

Internal MedicineLos Angeles, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$33
Payment records
1
By payment type
Food and Beverage$33
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
38
Unique beneficiaries
—
Total services
142
Distinct HCPCS
2
Medicare payment
$9K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10,499 Internal Medicine providers in CA — below median (cohort median 531).
REFERRAL NETWORK

Where Soo Chong's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SONOMED, LLC2266
Edward Rhee
Podiatry · Los Angeles, CA
1236
City Of Los Angeles
Ambulance Service Provider · Los Angeles, CA
1131
NPI 13068323991133
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
1,769
Beneficiaries
—
Total drug cost
$73K
Distinct drugs
53
Brand share
19.1%
Top prescribed drugs
Atorvastatin Calcium124 claims
Metformin Hcl115 claims
Amlodipine Besylate101 claims
Tamsulosin Hcl92 claims
Losartan Potassium89 claims